Biogen Inc. (BIIB)

Kronos Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	2,759	2,375	1,050	3,419	2,261	1,331
Short-Term Investments	-	-	-	1,474	1,541	1,279
Cash & Short-Term Investments	2,759	2,375	1,050	4,893	3,803	2,610
Cash Growth	44.52%	126.21%	-78.54%	28.67%	45.68%	-41.69%
Accounts Receivable	2,084	1,869	2,100	2,136	1,962	2,327
Other Receivables	-	-	430	798.8	-	-
Receivables	2,084	1,869	2,530	2,935	1,962	2,327
Inventory	2,274	2,461	2,527	1,344	1,352	1,069
Other Current Assets	850.6	752.5	752	618.8	740.8	881.1
Total Current Assets	7,968	7,457	6,859	9,791	7,857	6,887
Property, Plant & Equipment	3,433	3,538	3,730	3,703	3,792	3,845
Long-Term Investments	407	423.8	625.8	1,776	2,826	3,671
Goodwill	6,493	6,479	6,219	5,749	5,761	5,762
Other Intangible Assets	9,468	9,691	8,363	1,850	2,221	3,084
Long-Term Deferred Tax Assets	330.9	324.2	928.6	1,226	1,415	1,370
Other Long-Term Assets	200.7	136.7	119.2	459.3	5.5	-
Total Assets	28,330	28,049	26,845	24,554	23,877	24,619
Accounts Payable	408.4	424.2	403.3	491.5	589.2	454.9
Accrued Expenses	1,459	1,504	1,453	1,497	1,382	1,633
Current Portion of Long-Term Debt	-	1,749	150	-	999.1	-
Current Portion of Leases	-	86.4	90.3	97.2	89.1	83.2
Current Income Taxes Payable	114.8	548.3	257.4	259.9	174.7	142
Other Current Liabilities	1,202	1,218	1,080	927.6	1,064	1,429
Total Current Liabilities	3,184	5,529	3,434	3,273	4,298	3,742
Long-Term Debt	6,284	4,547	6,788	6,281	6,274	7,426
Long-Term Leases	310.9	334.5	400	333	330.4	402
Long-Term Deferred Tax Liabilities	118.3	190.5	641.8	334.7	694.5	1,033
Other Long-Term Liabilities	799.6	732.3	781.1	944.2	1,321	1,330
Total Liabilities	10,696	11,333	12,045	11,166	12,918	13,933
Common Stock	0.1	0.1	0.1	0.1	0.1	0.1
Additional Paid-In Capital	714	569.4	302.5	73.3	68.2	-
Retained Earnings	20,135	19,260	17,628	16,467	13,912	13,976
Treasury Stock	-2,977	-2,977	-2,977	-2,977	-2,977	-2,977
Comprehensive Income & Other	-238.1	-136.2	-153.7	-164.9	-106.7	-299
Total Common Equity	17,634	16,716	14,799	13,398	10,896	10,700
Minority Interest	-	-	-	-9.5	63.5	-14.2
Shareholders' Equity	17,634	16,716	14,799	13,388	10,960	10,686
Total Liabilities & Equity	28,330	28,049	26,845	24,554	23,877	24,619
Total Debt	6,595	6,717	7,429	6,711	7,693	7,911
Net Cash (Debt)	-3,836	-4,342	-6,379	-1,113	-2,998	-4,529
Net Cash Per Share	-26.22	-29.76	-43.81	-7.62	-20.04	-28.08
Filing Date Shares Outstanding	146.61	146.37	145.36	144.49	146.96	152.34
Total Common Shares Outstanding	146.6	145.8	144.9	144.1	147	152.4
Working Capital	4,784	1,928	3,425	6,518	3,558	3,145
Book Value Per Share	120.29	114.65	102.14	92.98	74.12	70.21
Tangible Book Value	1,673	545.9	217.2	5,799	2,914	1,854
Tangible Book Value Per Share	11.41	3.74	1.50	40.24	19.82	12.16
Land	-	202.4	202.4	202.4	207.5	119.8
Buildings	-	1,964	1,601	1,593	1,700	1,025
Machinery	-	2,169	1,765	1,673	1,653	1,090
Construction In Progress	-	308.4	975.4	888.8	770.3	1,951
Leasehold Improvements	-	137.8	135.7	107.7	121	104.6

Updated Jul 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q